Mitsubishi Tanabe Pharma America, Inc., announced the presentation of five abstracts in amyotrophic lateral sclerosis (ALS) at the XXVI World Congress of Neurology (WCN),...
Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery and development, announced...
Ionis Pharmaceuticals, Inc. announced that its partner Biogen has received U.S. Food and Drug Administration (FDA) approval of QALSODY 100 mg/15mL injection for the...
Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of inflammatory disorders and autoimmune diseases, today announced...
Argus Research, an independent investment research firm, has launched Argus Equity Report coverage on ProMIS Neurosciences, Inc.
Click here to view Full Argus Equity Report
Excerpts...
